BCRX
BioCryst Pharmaceuticals, Inc.
8.81
+
0.00
0.00%
13 x 8.80
18 x 8.79
bid
ask
16 @ 04:00 PM
8.60-0.21 (2.38%)
Bearish
32
Bullish
78
sentiment
8.75
day range
8.96
7.20
52 week range
15.43
Prev Close8.81
Open8.82
Low8.75
High8.96
Volume1.78M
Avg. Volume2.76M
Market Cap1.66B
Inst. Own87.08%
Beta2.01
Short Ratio12.29
Div & Yield0.00 /
EPS-1.23
P/E0.00
1yr Target15.15
50day MA8.26
200day MA11.26
^DJI
Dow Jones Industrial Average
33833.60
05:22 PM
+
168.60
0.50%
^IXIC
NASDAQ Composite
13238.50
05:15 PM
+
133.60
1.02%
^GSPC
S&P 500
4293.93
05:22 PM
+
26.41
0.62%
AAPL
180.50
-0.07 (0.04%)
Apple Inc.
180.57
12 @ 04:00 PM
14 x 180.50
10 x 180.53
+
2.75
1.55%
GOOG
122.40
-0.27 (0.22%)
Alphabet Inc.
122.67
10 @ 04:00 PM
12 x 122.25
8 x 122.45
-
0.27
0.22%
AMZN
124.02
-0.23 (0.19%)
Amazon.com, Inc.
124.25
10 @ 04:00 PM
11 x 124.08
8 x 124.05
+
3.02
2.49%
MSFT
323.70
-1.56 (0.48%)
Microsoft Corporation
325.26
9 @ 04:00 PM
8 x 323.61
9 x 325.00
+
1.88
0.58%
BABA
86.18
+0.04 (0.05%)
Alibaba Group Holding Limited
86.14
8 @ 04:01 PM
8 x 86.20
8 x 86.40
+
0.86
1.01%
NFLX
409.88
+0.51 (0.12%)
Netflix, Inc.
409.37
10 @ 04:00 PM
12 x 410.30
8 x 410.04
+
9.60
2.40%
TSLA
246.69
+11.83 (5.04%)
Tesla, Inc.
234.86
9 @ 04:00 PM
9 x 246.65
8 x 235.11
+
10.29
4.58%
NVDA
386.43
+1.32 (0.34%)
NVIDIA Corporation
385.10
12 @ 04:00 PM
14 x 386.45
9 x 386.48
+
10.35
2.76%
AMD
121.51
+0.46 (0.38%)
Advanced Micro Devices, Inc.
121.05
16 @ 04:00 PM
22 x 121.51
9 x 121.55
+
3.22
2.73%
MU
65.25
-0.07 (0.11%)
Micron Technology, Inc.
65.32
8 @ 04:00 PM
8 x 65.20
8 x 65.27
-
1.74
2.59%
SPY
428.84
-0.29 (0.07%)
SPDR S&P 500 ETF Trust
429.13
12 @ 04:00 PM
14 x 428.81
9 x 428.85
+
2.58
0.60%
TQQQ
36.23
+0.05 (0.14%)
ProShares UltraPro QQQ
36.18
119 @ 04:00 PM
22 x 36.32
215 x 36.29
+
1.20
3.43%
BRK-A
511795.00
-719.00 (0.14%)
Berkshire Hathaway Inc.
512514.00
9 @ 04:01 PM
8 x 490200.00
9 x 513136.00
+
719.00
0.14%
| Day Gain | ||
| Gain | ||
| Market Val | ||
| Costs | ||
| Cash | ||
| Portfolio | ||
| Realized | ||
| Dividend |
News
...
Profile
...
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat hereditary angioedema. It is also developing BCX9930, an oral factor D inhibitor for complement-mediated diseases; and Galidesivir, to treat various RNA viruses, including Marburg, Yellow Fever, Ebola, and Zika. The company has collaborations and in-license relationships with the Torii Pharmaceutical Co., Ltd.; Seqirus UK Limited; Shionogi & Co., Ltd.; Green Cross Corporation; National Institute of Allergy and Infectious Diseases; Biomedical Advanced Research and Development Authority; the U.S. Department of Health and Human Services; and The University of Alabama at Birmingham, as well as Albert Einstein College of Medicine of Yeshiva University and Industrial Research, Ltd. BioCryst Pharmaceuticals, Inc. was founded in 1986 and is headquartered in Durham, North Carolina.
Earning
...
| Date | For | Estimate | Reported | Surprise | surprise % |
|---|---|---|---|---|---|
| 2023-05-03 | 2023-03 | -0.3 | -0.28 | 0.02 | 6.67% |
| 2023-02-21 | 2022-12 | -0.19 | -0.38 | -0.19 | -100.00% |
| 2022-11-01 | 2022-09 | -0.32 | -0.23 | 0.09 | 28.13% |
| 2022-08-04 | 2022-06 | -0.36 | -0.32 | 0.04 | 11.11% |
| 2022-05-05 | 2022-03 | -0.39 | -0.4 | -0.01 | -2.56% |
| 2022-02-23 | 2021-12 | -0.31 | -0.4 | -0.09 | -29.03% |
Upgrade / Downgrade
...
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| 2023-05-04 | RBC Capital | Upgrade | Sector Perform | |
| 2023-05-04 | Needham | Upgrade | Buy | |
| 2023-04-20 | Evercore ISI Group | Upgrade | Outperform | |
| 2023-04-20 | Needham | Upgrade | Buy | |
| 2023-03-14 | RBC Capital | Upgrade | Sector Perform | |
| 2023-02-22 | JMP Securities | Upgrade | Market Outperform |
Insider Holder
...
| Date | Name | Relation | Quantity | Description |
|---|---|---|---|---|
| 2022-12-18 | BARNES ALANE P | Officer | 232.77K | Stock Award(Grant) |
| 2022-12-18 | GAYER CHARLES K | Officer | 245.61K | Stock Award(Grant) |
| 2023-05-30 | HEGGIE THERESA | Director | 32.37K | Stock Award(Grant) |
| 2023-02-27 | INGRAM ROBERT ALEXANDER | Director | 100.20K | Stock Award(Grant) |
| 2022-12-18 | JONES MICHAEL L. | Officer | 16.65K | Stock Award(Grant) |
| 2023-01-30 | LEE KENNETH B. | Director | 52.12K | Conversion of Exercise of derivative security |
Institution Ownership
...
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2023-03-30 | Blackrock Inc. | 14.82M | 130.61M | 7.85% |
| 2023-03-30 | Vanguard Group, Inc. (The) | 14.83M | 130.62M | 7.85% |
| 2023-03-30 | Baker Brothers Advisors, LLC | 12.71M | 111.98M | 6.73% |
| 2023-03-30 | State Street Corporation | 11.39M | 100.34M | 6.03% |
| 2023-03-30 | Avoro Capital Advisors LLC | 10.42M | 91.80M | 5.52% |
| 2023-03-30 | Pictet Asset Management SA | 5.62M | 49.50M | 2.97% |
Fund Ownership
...
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2023-02-27 | SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF | 6.52M | 57.43M | 3.46% |
| 2022-12-30 | Vanguard Total Stock Market Index Fund | 5.65M | 49.79M | 3.00% |
| 2023-02-27 | iShares Russell 2000 ETF | 4.10M | 36.12M | 2.18% |
| 2023-02-27 | Fidelity Select Portfolios - Biotechnology | 2.69M | 23.73M | 1.43% |
| 2022-12-30 | Vanguard Extended Market Index Fund | 2.52M | 22.19M | 1.34% |
| 2022-12-30 | Vanguard Small-Cap Index Fund | 2.40M | 21.16M | 1.27% |
Dividend
...
| Dividend | Date |
|---|---|
| 0 | 2014-06-11 |
| 0 | 2014-06-05 |
| 0 | 2014-05-20 |
| 0 | 2014-05-16 |
| 0 | 2014-04-02 |
This topic has been deleted. Only users with topic management privileges can see it.
-
$BCRX 15 SHARES Pre mkt.
-
$BCRX Marango give it up buddy spew your loser garbage somewhere else move on!
-
$BCRX Glad I’ve got a $1.92 avg.
-
$BCRX this could be the next CCXI….then mabe NOT!
-
$BCRX News flash we are up $3.03 from 3/15/2018 wow!
-
$BCRX I mean sell some more.
-
$BCRX 9 scripts …1.25 scripts per continent Boy we are tearing um up better buy some more shares
-
$BCRX Maphere folded his tent and moved to CLSD a few weeks back
-
$BCRX It’s ashamed this board is turning into a nursery play room
-
$BCRX Another day of baby Joey
-
$BCRX @Joey Go away you lost. Take it like a man move on get off the lot see u later!
-
$BCRX Man oh man holding since 2019 through ups and downs kept the faith but it’s getting hard we are sitting here on a day we should be running and the shorts are sticking it to us what to do
-
$BCRX Let’s get um Horned Frogs
-
-
$BCRX Well we’ve got us a new cry baby
-
-
$BCRX 2023 Watch for headers and lifts and tack on the shifts same as 2022
-
$BCRX Alright it’s time to head back north and close at the HOD
-
$BCRX Bzzzz Bzzzz
-
Considering BioCryst Pharmaceuticals Inc. (BCRX) as a potential ...
news.google.com •
